Answers are grounded in this paper and cite their sources.
An operationalized workflow paradigm is presented and validated with pilot subject data. This approach is reproducible with a high concordance rate between individual readers (kappa 0.73 [confidence interval 0.59-0.87; P=<0.0001]) using a 5-point scale to assess [¹⁸F] labeled fluorodeoxyglucose metabolic activity in lymphomatous lesions. These results suggest an operationally practical 5-point scale workflow paradigm for potential use in larger clinical trials evaluating lymphoma therapeutics.
No takes yet. Share an insight, caveat, or question.
Heertum et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: